Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097357 · ClinicalTrials.gov registry record · Phase 2
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
A Phase 2 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,238
- Enrollment target
NCT00097357: Completed Phase 2 study, sponsored by Bristol-Myers Squibb.
NCT00097357 is a Phase 2 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 1,238 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (831% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00097357, a Phase 2 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,238 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.
Interventions
- DRUG Apixaban
- DRUG Enoxaparin
- DRUG Warfarin
- DRUG Apixaban Placebo
- DRUG Enoxaparin Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,238 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
What the finished NCT00097357 record still lists
NCT00097357 is an interventional study that assigns participants to a tested intervention. Its 1,238 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (831% higher).
The record links to 0 conditions, and to 5 interventions - of which Apixaban is the first listed.
NCT00097357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00097357 about?
NCT00097357 is a clinical study titled "BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery". The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.
What is the current status of trial NCT00097357?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,238 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00097357?
The interventions under investigation include: Apixaban (DRUG), Enoxaparin (DRUG), Warfarin (DRUG), Apixaban Placebo (DRUG), Enoxaparin Placebo (DRUG).
Who is sponsoring clinical trial NCT00097357?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00097357's enrollment target sits among peer trials
1,238 16th of 2000 higher than 1,985 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia